13.05 +0.10 (0.77%)
ALNY
| Trade ALNY now with |
|
Stock Details
Last Trade:13.05 Change:+0.10 (0.77%) Prev Close:12.95 Open: 13.02 Days Range:12.65 – 13.15 52 Week Range: 5.88 - 13.25 Volume:569477 P/E: N/AEPS:-1.19
View AllRecent Alerts 02/09/12
Recent Alert on 02/08/12 at 6:04pm
Trading Radar for 02/09: Sirius XM (SIRI), PepsiCo (PEP), Expedia (EXPE), Dunkin' Brands (DNKN), Linkedin (LNKD), Activision (ATVI) Report
Trading Radar for 02/09: Sirius XM (SIRI), PepsiCo (PEP), Expedia (EXPE), Dunkin' Brands (DNKN), Linkedin (LNKD), Activision (ATVI) Report
The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session: Before The Market Opens Economic: 8:30am ESTInitial Claims - Street sees 370K Continuing Claims - Street sees 3475KEarnings: API... Read More
Recent Alert on 01/30/12 at 8:03am
Alnylam Pharma (ALNY) Receives Notice of Allowance Covering 2G LNP Platform
Alnylam Pharma (ALNY) Receives Notice of Allowance Covering 2G LNP Platform
Recent Alert on 01/30/12 at 8:03am
Alnylam Pharma (ALNY) Receives Notice of Allowance Covering 2G LNP Platform
Alnylam Pharma (ALNY) Receives Notice of Allowance Covering 2G LNP Platform
Recent Alert on 01/19/12 at 6:01pm
Alnylam (ALNY) Announces Restructuring: Will Cut 33% of Workforce, Sees $4M in Charges
Alnylam (ALNY) Announces Restructuring: Will Cut 33% of Workforce, Sees $4M in Charges
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 01/30/12 at 9:07am
Verastem IPO Validates Investor Interest In Cancer Stem Cell Approach
Verastem IPO Validates Investor Interest In Cancer Stem Cell Approach